29633
Two other drugs , trastuzumab emtansine and brentuximab vedotin , are both in late clinical trials , and the latter has been granted accelerated approval for the treatment of refractory Hodgkin 's lymphoma and systemic anaplastic large cell lymphoma .
 person: Hodgkin
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: location, person, organization 
Text: {0} 
 Entities: Hodgkin 
Answer:
 person: Hodgkin